Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Incorporated (VRTX $421.11)
- $421.11 P/E (TTM): 27.73X Cap: $109.37B
- View VRTX Profile
- View Questions on VRTX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $454.15)
- $454.15 P/E (TTM): 55.62X Cap: $160.20B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $421.11)
- $421.11 P/E (TTM): 27.73X Cap: $109.37B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $207.32)
- $207.32 P/E (TTM): 87.54X Cap: $368.18B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $225.83)
- $225.83 P/E (TTM): 20.6X Cap: $539.69B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $979.08)
- $979.08 P/E (TTM): 41.98X Cap: $911.53B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $113.16)
- $113.16 P/E (TTM): 15.41X Cap: $279.52B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $169.80)
- $169.80 P/E (TTM): 23.15X Cap: $8.06B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $574.87)
- $574.87 P/E (TTM): 43.38X Cap: $44.77B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $66.84)
- $66.84 P/E (TTM): 25.28X Cap: $7.64B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $97.05)
- $97.05 P/E (TTM): 15.12X Cap: $19.40B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $29.63)
- $29.63 P/E (TTM): 17.01X Cap: $3.53B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $27.07)
- $27.07 P/E (TTM): 19.42X Cap: $224.29B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

Vertex Pharmaceuticals Incorporated (VRTX $421.11)
- $421.11 P/E (TTM): 27.73X Cap: $109.37B
- View VRTX Profile
- View Questions on VRTX
CRISPR Therapeutics AG (CRSP $50.18)
- $50.18 Cap: $5.16B
- View CRSP Profile
- View Questions on CRSP

Q: What is your opinion regarding the future of CRSP? Buy, sell, hold?

Read Answer Asked by Judith on May 21, 2025

Vertex Pharmaceuticals Incorporated (VRTX $421.11)
- $421.11 P/E (TTM): 27.73X Cap: $109.37B
- View VRTX Profile
- View Questions on VRTX

Q: May I please get your thoughts on this company? I like their new non-opioid pain killer that was just approved by the FDA for a strong growth prospect. I am curious what you think about the existing business and the fundamentals/financials of the company. Thanks.

Read Answer Asked by Marco on February 14, 2025